1. Should Off-Label Drugs Be Included as Comparators in Pharmacoeconomic Studies?

   • Surrey M. Walton
   • Glen T. Schumock

   Editorial 01 October 2014 Pages: 1035 - 1037

2. NICE, Social Values, and Balancing Objectivity and Equity

   • Suzanne R. Hill
   • Leslie G. Olson

   Commentary 24 September 2014 Pages: 1039 - 1041

3. Some Inconsistencies in NICE’s Consideration of Social Values

   • Mike Paulden
   • James F. O’Mahony
   • Christopher McCabe

   Leading Article 22 August 2014 Pages: 1043 - 1053

   

4. Through a Glass Darkly: Economics and Personalised Medicine

   • Alan Haycox
   • Munir Pirmohamed
   • Sarah Richards

   Practical Application 14 August 2014 Pages: 1055 - 1061

5. Cost Effectiveness of Treatments for non-ST-segment elevation Acute Coronary Syndrome

   • Fotini Gialama
   • Evangelia Miloni
   • Nikos Maniadakis

   Systematic Review 01 August 2014 Pages: 1063 - 1078

   

6. Cost Effectiveness of Liraglutide in Type II Diabetes: A Systematic Review

   • Patrick M. Zueger
   • Neil M. Schultz
   • Todd A. Lee

   Systematic Review 23 July 2014 Pages: 1079 - 1091

   

7. The Health Economics of Bladder Cancer: An Updated Review of the Published Literature

   • Christina Yeung
   • Tuan Dinh
   • Joseph Lee

   Review Article 24 July 2014 Pages: 1093 - 1104

8. A Review of Approaches for the Management of Specialty Pharmaceuticals in the United States

   • Bijal Nitin Patel
   • Patricia R. Audet

   Review Article Open access 14 August 2014 Pages: 1105 - 1114

9. Preferences for Oral Anticoagulants in Atrial Fibrillation: a Best–Best Discrete Choice Experiment

   • Peter Ghijben
   • Emily Lancsar
   • Silva Zavarsek

   Original Research Article 16 July 2014 Pages: 1115 - 1127

   

10. Evaluating Disease-Modifying Agents: A Simulation Framework for Alzheimer’s Disease

    • Shien Guo
    • Denis Getsios
    • Maren Gaudig

    Original Research Article 15 August 2014 Pages: 1129 - 1139

    

11. The Problem of Embedded Decision Nodes in Cost-Effectiveness Decision Trees

    • Manuel Arias
    • Francisco Javier Díez

    Research Letter 31 July 2014 Pages: 1141 - 1145